Extrafine triple therapy in patients with asthma and persistent airflow limitation

Eur Respir J. 2020 Sep 24;56(3):2000476. doi: 10.1183/13993003.00476-2020. Print 2020 Sep.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Asthmatic Agents* / therapeutic use
  • Asthma* / drug therapy
  • Humans
  • Lung

Substances

  • Anti-Asthmatic Agents

Associated data

  • ClinicalTrials.gov/NCT02676076
  • ClinicalTrials.gov/NCT02676089